Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer.

Purpose: Alanine-serine-cysteine transporter 2 (ASCT2) expression has been demonstrated as a promising lung cancer biomarker. (2S,4R)-4-[(18)F]Fluoroglutamine (4-[(18)F]fluoro-Gln) positron emission tomography (PET) was evaluated in preclinical models of non-small cell lung cancer as a quantitative,...

Full description

Bibliographic Details

Published in:	Molecular Imaging & Biology Vol. 18; no. 1; pp. 18 - 24
Main Authors:	Hassanein, Mohamed, Hight, Matthew, Buck, Jason, Tantawy, Mohammed, Nickels, Michael, Hoeksema, Megan, Harris, Bradford, Boyd, Kelli, Massion, Pierre, Manning, H., Hight, Matthew R, Buck, Jason R, Tantawy, Mohammed N, Nickels, Michael L, Hoeksema, Megan D, Harris, Bradford K, Massion, Pierre P, Manning, H Charles
Format:	diagnostic images pictorial research tables/charts Journal Article
Published:	Springer Nature Feb2016
Online Access:	View this record in EBSCOhost